Empagliflozin 5 MG + Metformin 500 MG Tablets – A practical and comprehensive approach to managing T2DM.
EMPIGA M 5/500 Tablets – The Dual composition of Empagliflozin 5mg + Metformin 500mg is designed to provide comprehensive control over Type 2 Diabetes by leveraging the complementary actions of Empagliflozin and Metformin. Empagliflozin: A sodium-glucose cotransporter-2 (SGLT2) inhibitor that helps lower blood sugar by preventing glucose reabsorption in the kidneys. It also promotes weight loss and provides cardiovascular protection. Metformin: A biguanide that decreases glucose production in the liver, improves insulin sensitivity, and enhances peripheral glucose uptake.
Recommended By Specialists:
✅ Endocrinologists: It is preferred to treat the disease associated with First-line specialists for comprehensive diabetes management.
✅ General Physicians –It is preferred to treat the disease associated with routine management of type 2 diabetes in stable patients.
✅ Cardiologists— Empagliflozin is preferred for treating the diseases associated with diabetic patients with cardiovascular disease since It also provides cardio-renal protection.
Key Benefits of Empagliflozin 5 MG + Metformin 500 MG Tablets – EMPIGA M 5/500 Tablets:
✅ Dual Action Formula: This formula combines the blood sugar-lowering effects of Empagliflozin, an SGLT2 inhibitor, with Metformin, a well-known biguanide, for superior glycemic control.
✅ Weight and Cardiovascular Benefits: Empagliflozin helps with weight management and provides cardiovascular benefits, reducing the risk of heart-related events in diabetic patients.
✅ Convenient Dosage: Offers a once-daily, dual-action approach to managing Type 2 Diabetes, improving patient adherence and simplifying treatment.
INDICATIONS:
✅ Type 2 Diabetes Mellitus
✅ To improve glycemic control in patients with inadequate blood sugar control
✅ Cardiovascular risk reduction in patients with Type 2 Diabetes